(Q37738019)

22 August 2017

1 reference

title

The evolution of renin-angiotensin blockade: angiotensin-converting enzyme inhibitors as the starting point (English)

1 reference

22 August 2017

Domenic A Sica

1

1 reference

22 August 2017

publication date

1 April 2010

1 reference

Current Hypertension Reports

22 August 2017

published in

1 reference

22 August 2017

volume

12

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

67-73

1 reference

Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-010-0091-9

Angiotensin-Converting Enzyme Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-010-0091-9

Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-010-0091-9

Converting enzyme inhibition with an orally active compound in hypertensive man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-010-0091-9

Pharmacokinetics of enalapril in congestive heart failure

21 January 2018

1 reference

12 December 2020

Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology

1 reference

12 December 2020

Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

1 reference

12 December 2020

Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers

1 reference

12 December 2020

Measurement of angiotensin I converting enzyme inhibition in the heart

1 reference

12 December 2020

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Associa

1 reference

12 December 2020

Cough induced by quinapril with resolution after changing to fosinopril

1 reference

12 December 2020

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

1 reference

12 December 2020

Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

12 December 2020

Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors

1 reference

12 December 2020

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

12 December 2020

A Comparison of the Cough Profile of Fosinopril and Enalapril in Hypertensive Patients with a History of ACE Inhibitor-Associated Cough

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors side effects--physiologic and non-physiologic considerations

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

The Heart Outcomes Prevention Evaluation study: angiotensin-converting enzyme inhibitors: are their benefits a class effect or do individual agents differ?

1 reference

12 December 2020

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

12 December 2020

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

12 December 2020

Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure

1 reference

12 December 2020

From kinetics to dynamics: are there differences between ACE inhibitors?

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease

1 reference

12 December 2020

Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

12 December 2020

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

1 reference

12 December 2020

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

1 reference

12 December 2020

Membranous glomerulopathy associated with captopril therapy

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

12 December 2020

Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy?

1 reference

12 December 2020

Choosing the right ACE inhibitor. A guide to selection

1 reference

12 December 2020

The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11906-010-0091-9

Identifiers

DOI

1 reference

22 August 2017

1 reference